World PulseNow
Newsletter

Piper Sandler raises Exact Sciences stock price target to $70 on Cologuard growth

Investing.com•Wednesday, October 8, 2025 at 1:46:17 PM
PositiveFinancial Markets
Piper Sandler raises Exact Sciences stock price target to $70 on Cologuard growth
Piper Sandler has raised its price target for Exact Sciences to $70, driven by the anticipated growth of Cologuard, a non-invasive colorectal cancer screening test. This adjustment reflects confidence in the company's innovative approach to cancer detection and its potential to capture a larger market share. Investors and stakeholders should pay attention, as this could signal a positive trend for Exact Sciences and its role in improving patient outcomes.
— Curated by the World Pulse Now AI Editorial System
Read Original

Was this article worth reading? Share it

Recommended Readings
Piper Sandler reiterates Overweight rating on Rithm Capital stock
Investing.com3 hours ago
Piper Sandler reiterates Overweight rating on Rithm Capital stock
PositiveFinancial Markets
Piper Sandler has reaffirmed its Overweight rating on Rithm Capital stock, signaling confidence in the company's potential for growth. This endorsement is significant as it reflects the firm's belief in Rithm's strong fundamentals and market position, which could attract more investors and positively influence stock performance.
Read full article
via Investing.com
Shell stock price target raised to $87 from $82 at Piper Sandler
Investing.com3 hours ago
Shell stock price target raised to $87 from $82 at Piper Sandler
PositiveFinancial Markets
Piper Sandler has raised its price target for Shell's stock from $82 to $87, reflecting a positive outlook on the company's performance. This adjustment indicates confidence in Shell's ability to navigate market challenges and capitalize on growth opportunities, which is significant for investors looking for stability and potential gains in the energy sector.
Read full article
via Investing.com
Piper Sandler reiterates Overweight rating on Autodesk stock
Investing.com3 hours ago
Piper Sandler reiterates Overweight rating on Autodesk stock
PositiveFinancial Markets
Piper Sandler has reaffirmed its Overweight rating on Autodesk stock, indicating strong confidence in the company's future performance. This is significant as it reflects the firm's belief in Autodesk's growth potential and market position, which could influence investor sentiment and stock prices positively.
Read full article
via Investing.com
Crinetics stock holds Overweight rating at Piper Sandler after acromegaly drug approval
Investing.com3 hours ago
Crinetics stock holds Overweight rating at Piper Sandler after acromegaly drug approval
PositiveFinancial Markets
Crinetics Pharmaceuticals has received an Overweight rating from Piper Sandler following the approval of its acromegaly drug. This positive assessment reflects confidence in the company's growth potential and the effectiveness of its new treatment, which addresses a significant medical need. Investors are likely to view this news favorably, as it suggests a promising future for Crinetics in the competitive pharmaceutical market.
Read full article
via Investing.com
Piper Sandler assumes coverage on Equity Bancshares stock with Overweight rating
Investing.com8 hours ago
Piper Sandler assumes coverage on Equity Bancshares stock with Overweight rating
PositiveFinancial Markets
Piper Sandler has initiated coverage on Equity Bancshares with an Overweight rating, signaling strong confidence in the company's future performance. This move is significant as it reflects the firm's belief in Equity Bancshares' potential for growth, which could attract more investors and positively impact the stock's market position.
Read full article
via Investing.com
Piper Sandler raises Arvinas stock price target to $16 on LRRK2 degrader data
Investing.coma day ago
Piper Sandler raises Arvinas stock price target to $16 on LRRK2 degrader data
PositiveFinancial Markets
Piper Sandler has raised its stock price target for Arvinas to $16, following promising data on the LRRK2 degrader. This adjustment reflects growing confidence in Arvinas' potential to innovate in the biotech sector, particularly in treatments for neurodegenerative diseases. Investors are likely to view this as a positive sign, indicating that the company's research is gaining traction and could lead to significant advancements in patient care.
Read full article
via Investing.com
Fifth Third Bancorp stock price target lowered to $48 by Piper Sandler
Investing.coma day ago
Fifth Third Bancorp stock price target lowered to $48 by Piper Sandler
NegativeFinancial Markets
Fifth Third Bancorp has seen its stock price target lowered to $48 by Piper Sandler, indicating a shift in market expectations for the bank's performance. This adjustment reflects concerns about the financial sector's stability and could impact investor confidence. Understanding these changes is crucial for stakeholders as they navigate the evolving landscape of banking and finance.
Read full article
via Investing.com
Piper Sandler lowers ExxonMobil stock price target to $141 on timing effects
Investing.coma day ago
Piper Sandler lowers ExxonMobil stock price target to $141 on timing effects
NegativeFinancial Markets
Piper Sandler has reduced its price target for ExxonMobil's stock to $141, citing timing effects that could impact the company's performance. This adjustment reflects concerns about the oil giant's ability to navigate current market conditions effectively. Investors should pay attention to these changes as they may influence ExxonMobil's stock trajectory and overall market confidence.
Read full article
via Investing.com
AMD stock price target raised to $240 from $190 at Piper Sandler
Investing.coma day ago
AMD stock price target raised to $240 from $190 at Piper Sandler
PositiveFinancial Markets
AMD's stock price target has been raised from $190 to $240 by Piper Sandler, reflecting strong confidence in the company's growth potential. This adjustment is significant as it indicates analysts' optimism about AMD's future performance, especially in the competitive semiconductor market. Investors may see this as a positive signal, potentially driving more interest and investment in AMD.
Read full article
via Investing.com
Citi stock holds Overweight rating at Piper Sandler amid Banamex sale
Investing.com2 days ago
Citi stock holds Overweight rating at Piper Sandler amid Banamex sale
PositiveFinancial Markets
Citi's stock has received an Overweight rating from Piper Sandler, particularly in light of the ongoing sale of Banamex. This positive outlook reflects confidence in Citi's strategic moves and potential for growth, making it an interesting time for investors to consider their positions in the bank. The sale of Banamex is a significant step for Citi, and analysts believe it could enhance the bank's overall performance.
Read full article
via Investing.com
Piper Sandler reiterates Overweight rating on Brixmor Property stock
Investing.com2 days ago
Piper Sandler reiterates Overweight rating on Brixmor Property stock
PositiveFinancial Markets
Piper Sandler has reaffirmed its Overweight rating on Brixmor Property stock, signaling confidence in the company's performance and potential for growth. This endorsement is significant as it reflects the firm's belief in Brixmor's ability to navigate market challenges and deliver value to investors, making it a noteworthy consideration for those looking to invest in real estate.
Read full article
via Investing.com
Piper Sandler reiterates Overweight rating on Alkermes stock ahead of trial
Investing.com2 days ago
Piper Sandler reiterates Overweight rating on Alkermes stock ahead of trial
PositiveFinancial Markets
Piper Sandler has reaffirmed its Overweight rating on Alkermes stock as the company approaches a significant trial. This endorsement is crucial as it reflects confidence in Alkermes' potential to perform well in the market, especially with the upcoming trial that could impact its future. Investors often look for such ratings to gauge the viability of their investments, making this news particularly relevant for those tracking Alkermes.
Read full article
via Investing.com
Latest from Financial Markets
Liontrust Investment Partners reduces stake in Eagle Eye Solutions
Investing.com11 minutes ago
Liontrust Investment Partners reduces stake in Eagle Eye Solutions
NeutralFinancial Markets
Liontrust Investment Partners has reduced its stake in Eagle Eye Solutions, a move that reflects ongoing adjustments in their investment strategy. This change is significant as it may indicate a shift in confidence or a strategic realignment within the investment landscape, prompting investors to consider the implications for both firms.
Read full article
via Investing.com
State Street stock hits all-time high at 118.07 USD
Investing.com12 minutes ago
State Street stock hits all-time high at 118.07 USD
PositiveFinancial Markets
State Street's stock has reached an all-time high of 118.07 USD, marking a significant milestone for the company and reflecting strong investor confidence. This surge in stock price is important as it indicates the company's robust performance and potential for future growth, which can attract more investors and positively impact the overall market.
Read full article
via Investing.com
Adaptive Biotechnologies stock hits 52-week high at $15.29
Investing.com15 minutes ago
Adaptive Biotechnologies stock hits 52-week high at $15.29
PositiveFinancial Markets
Adaptive Biotechnologies has reached a significant milestone as its stock price hit a 52-week high of $15.29. This achievement reflects growing investor confidence in the company's innovative approaches to biotechnology and its potential for future growth. Such a rise in stock price not only boosts the company's market presence but also signals positive trends in the biotech sector, making it an exciting time for investors and stakeholders alike.
Read full article
via Investing.com
Silvercorp Metals stock hits 52-week high at 7.34 USD
Investing.com18 minutes ago
Silvercorp Metals stock hits 52-week high at 7.34 USD
PositiveFinancial Markets
Silvercorp Metals has reached a significant milestone, hitting a 52-week high of 7.34 USD per share. This achievement reflects the company's strong performance and growing investor confidence, which is crucial in the competitive mining sector. As the market responds positively, it highlights the potential for further growth and stability in Silvercorp's operations.
Read full article
via Investing.com
Buy pullbacks in silver as it remains cheap relative to gold: UBS
Investing.com28 minutes ago
Buy pullbacks in silver as it remains cheap relative to gold: UBS
PositiveFinancial Markets
UBS has advised investors to consider buying silver during price pullbacks, highlighting that it remains undervalued compared to gold. This recommendation is significant as it suggests a potential opportunity for investors to capitalize on silver's price movements, especially in a market where gold often overshadows it. By focusing on silver, investors may find a valuable asset that could yield returns as market dynamics shift.
Read full article
via Investing.com
NeoVolta Expands Portfolio With Neubau Energy Acquisition, Targeting Higher Revenues and Margins
Investing.com34 minutes ago
NeoVolta Expands Portfolio With Neubau Energy Acquisition, Targeting Higher Revenues and Margins
PositiveFinancial Markets
NeoVolta has made a strategic move by acquiring Neubau Energy, which is expected to enhance its portfolio and drive higher revenues and profit margins. This acquisition not only strengthens NeoVolta's position in the energy market but also reflects its commitment to growth and innovation. By integrating Neubau's capabilities, NeoVolta aims to deliver better solutions to its customers and capitalize on emerging opportunities in the energy sector.
Read full article
via Investing.com